109 related articles for article (PubMed ID: 16381998)
1. Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
Pentti K; Honkanen R; Tuppurainen MT; Sandini L; Kröger H; Saarikoski S
Eur J Endocrinol; 2006 Jan; 154(1):101-7. PubMed ID: 16381998
[TBL] [Abstract][Full Text] [Related]
2. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.
Pentti K; Tuppurainen MT; Honkanen R; Sandini L; Kröger H; Alhava E; Saarikoski S
Maturitas; 2009 May; 63(1):73-8. PubMed ID: 19394167
[TBL] [Abstract][Full Text] [Related]
3. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR
Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
[TBL] [Abstract][Full Text] [Related]
6. Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study.
Pentti K; Tuppurainen MT; Honkanen R; Sandini L; Kröger H; Alhava E; Saarikoski S
Eur J Endocrinol; 2009 Jun; 160(6):979-83. PubMed ID: 19321660
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women.
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
J Intern Med; 2004 Nov; 256(5):437-45. PubMed ID: 15485480
[TBL] [Abstract][Full Text] [Related]
8. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.
Fletcher AS; Erbas B; Kavanagh AM; Hart S; Rodger A; Gertig DM
Breast; 2005 Jun; 14(3):192-200. PubMed ID: 15927828
[TBL] [Abstract][Full Text] [Related]
9. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
11. Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.
Dinger J; Bardenheuer K; Heinemann K
Climacteric; 2016 Aug; 19(4):349-56. PubMed ID: 27174159
[TBL] [Abstract][Full Text] [Related]
12. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
Alexandersen P; Riis BJ; Christiansen C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis.
Hodis HN; Mack WJ
J Steroid Biochem Mol Biol; 2014 Jul; 142():68-75. PubMed ID: 23851166
[TBL] [Abstract][Full Text] [Related]
14. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
[TBL] [Abstract][Full Text] [Related]
15. Does hormone-replacement therapy prevent fractures in early postmenopausal women?
Randell KM; Honkanen RJ; Kröger H; Saarikoski S
J Bone Miner Res; 2002 Mar; 17(3):528-33. PubMed ID: 11874244
[TBL] [Abstract][Full Text] [Related]
16. Vaginal estradiol use and the risk for cardiovascular mortality.
Mikkola TS; Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
Hum Reprod; 2016 Apr; 31(4):804-9. PubMed ID: 26874358
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women.
Cerne JZ; Ferk P; Leskosek B; Gersak K
Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone replacement therapy and risk of cholecystectomy: a prospective cohort study.
Nordenvall C; Oskarsson V; Sadr-Azodi O; Orsini N; Wolk A
Scand J Gastroenterol; 2014 Jan; 49(1):109-13. PubMed ID: 24256204
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle influences on the association between pre-diagnostic hormone replacement therapy and breast cancer prognosis - results from The Danish 'Diet, Cancer and Health' prospective cohort.
Holm M; Olsen A; Kroman N; Tjønneland A
Maturitas; 2014 Dec; 79(4):442-8. PubMed ID: 25304746
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
Jiang Y; Xie Q; Chen R
Clin Breast Cancer; 2022 Feb; 22(2):e206-e213. PubMed ID: 34548240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
